Cadence Neuroscience has filed a notice of an exempt offering of securities to raise $26,029,994.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Cadence Neuroscience is raising $26,029,994.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Kent Leyde played a…
